Envisagenics Raises Series A Financing to Scale Its AI-powered RNA Splicing Drug Discovery Platform



Comments are closed.

Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases
Atomwise Raises $45 Million Series A
DigiLens Secures Investment from UDC Ventures and Samsung Ventures for Holographic AR Displays
Tetra Therapeutics announces positive topline results from Phase 2 study of BPN14770 in patients with Fragile X Syndrome